Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A paroxysmal dyskinesia which manifest as dystonic movements brought on by sustained exercise, that is correlated with a deficiency in the gene ECHS1 (caused by a missence mutation). Onset is typically between age two and four years.
No clinical trials have been registered for ECHS1-related paroxysmal dyskinesia.
1 publication has been identified in PubMed for ECHS1-related paroxysmal dyskinesia. Research spans Review / Meta-Analysis (100%).
Garris J (2025). [PMID: 40534755](https://pubmed.ncbi.nlm.nih.gov/40534755/). *Epilepsy Curr*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 2:55 PM UTC
Common questions about ECHS1-related paroxysmal dyskinesia
AI-curated news mentioning ECHS1-related paroxysmal dyskinesia
Updated Mar 11, 2026
New research identifies missense variants in the FGF13 gene as a novel cause of paroxysmal dyskinesia. This discovery could enhance understanding and treatment options for patients affected by this rare movement disorder.